Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Buy
14,486
+940
+7% +$45.8K 0.01% 794
2026
Q1
$581K Buy
13,546
+362
+3% +$15.6K 0.01% 821
2025
Q4
$578K Buy
13,184
+4,335
+49% +$179K 0.01% 805
2025
Q3
$365K Sell
8,849
-460
-5% -$18.5K 0.01% 937
2025
Q2
$407K Sell
9,309
-1,285
-12% -$51.4K 0.01% 895
2025
Q1
$386K Buy
10,594
+442
+4% +$15.7K 0.01% 872
2024
Q4
$338K Sell
10,152
-135
-1% -$4.38K 0.01% 908
2024
Q3
$244K Buy
10,287
+459
+5% +$11.4K 0.01% 947
2024
Q2
$221K Sell
9,828
-459
-4% -$10.2K 0.01% 1002
2024
Q1
$244K Sell
10,287
-1,387
-12% -$30.8K 0.01% 945
2023
Q4
$280K Sell
11,674
-235
-2% -$5.11K 0.01% 895
2023
Q3
$260K Buy
11,909
+306
+3% +$6.4K 0.01% 851
2023
Q2
$222K Buy
+11,603
New +$224K 0.01% 882
2022
Q1
Sell
-12,455
Closed -$228K 757
2021
Q4
$228K Sell
12,455
-8,501
-41% -$163K 0.02% 585
2021
Q3
$443K Buy
20,956
+5,635
+37% +$105K 0.05% 389
2021
Q2
$279K Buy
+15,321
New +$357K 0.03% 457

Other funds holding EXEL

Ethic Inc's EXEL Position: Q2 2026 in Review

Ethic Inc increased its Exelixis (EXEL) stake by 6.9% in Q2 2026, buying an estimated $45.8K and bringing the position to 14,486 shares worth $788K. The position accounts for 0.01% of the portfolio, ranked #794.

Ethic Inc first reported a position in EXEL in Q2 2021 and has held it in 16 quarters since. 227 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Ethic Inc held 14,486 shares of Exelixis worth $788K as of Q2 2026.
  • Ethic Inc bought 940 Exelixis shares in Q2 2026, an estimated $45.8K.
  • Exelixis made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #794 holding.
  • Ethic Inc first reported a position in Exelixis in Q2 2021 and has held it in 16 quarters since.
  • 227 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.